NCCN Guidelines® insights: Melanoma, version 3.2016: Featured updates to the NCCN Guidelines

Daniel G. Coit, John A. Thompson, Alain Algazi, Robert Andtbacka, Christopher K. Bichakjian, William E.Carson Iii, Gregory A. Daniels, Dominick Dimaio, Ryan C. Fields, Martin D. Fleming, Brian Gastman, Rene Gonzalez, Valerie Guild, Douglas Johnson, Richard W. Joseph, Julie R. Lange, Mary C. Martini, Miguel A. Materin, Anthony J. Olszanski, Patrick OttAparna Priyanath Gupta, Merrick I. Ross, April K. Salama, Joseph Skitzki, Susan M. Swetter, Kenneth K. Tanabe, Javier F. Torres-Roca, Vijay Trisal, Marshall M. Urist, Nicole McMillian, Anita Engh

Research output: Contribution to journalArticlepeer-review

61 Scopus citations


The NCCN Guidelines for Melanoma have been significantly revised over the past few years in response to emerging data on a number of novel agents and treatment regimens. These NCCN Guidelines Insights summarize the data and rationale supporting extensive changes to the recommendations for systemic therapy in patients with metastatic or unresectable melanoma.

Original languageEnglish (US)
Pages (from-to)945-958
Number of pages14
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number8
StatePublished - Aug 1 2016

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'NCCN Guidelines<sup>®</sup> insights: Melanoma, version 3.2016: Featured updates to the NCCN Guidelines'. Together they form a unique fingerprint.

Cite this